Drug Target Review2025-10-07T14:58:46
Researchers have developed bioactive nanoparticles that restore the brain’s blood-brain barrier and clear toxic proteins, reversing Alzheimer’s symptoms in mice and offering a promising new approach to treating the disease.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-11-16T07:00:00Z
Author Dr Martin Baraibar
2026-11-13T07:00:00Z
Contributor Dr Panos Roussos, Drug Target Review
2026-09-22T07:00:00
Contributor Luca Lotta, Drug Target Review
2026-11-13T07:00:00
Contributor Dr Panos Roussos, Drug Target Review
2026-03-11T14:00:00
Sponsored by Merck
2026-10-07T14:00:00
Sponsored by WuXi AppTec
2025-11-13T14:00:00
Sponsored by Cell Signaling Technology
2023-03-02T13:57:58
Sponsored by Cell Signaling Technology
Site powered by Webvision Cloud